Results 1 to 10 of about 96,064 (266)
Frontiers in Endocrinology, 2023 IntroductionCardiovascular diseases (CVD) and metabolic disorders (MD) have retained leading positions in the structure of morbidity and mortality for many years.
Ekaterina A. Dobreva +8 more
doaj +1 more source
International Journal of Endocrinology, 2022 Background. The BRAF V600E mutation is an important genetic event in papillary thyroid cancer (PTC). This study aimed to provide additional information regarding the association of the BRAF V600E mutation with PTC prognosis. Methods.
Ziheng Ye +6 more
doaj +1 more source
The Russian registry of primary hyperparathyroidism, latest update
Frontiers in Endocrinology, 2023 IntroductionUntil recently no major epidemiological research of primary hyperparathyroidism (PHPT) has been conducted in the Russian Federation, this led to the creation of the Russian online registry.
Natalia G. Mokrysheva +14 more
doaj +1 more source
BMC Surgery, 2021 Background To investigate the association between postoperative lymph nodes (LNs) recurrence and distinct serum thyroglobulin (Tg) levels in patients with papillary thyroid carcinoma (PTC).
Zhichao Xing +6 more
doaj +1 more source
Diagnostic performance of ultrasound risk stratification systems on thyroid nodules cytologically classified as indeterminate: a systematic review and meta-analysis [PDF]
Ultrasonography, 2023 Purpose Ultrasound (US) risk stratification systems (RSSs) are increasingly being utilized for the optimal management of thyroid nodules, including those with indeterminate cytology.
Zhichao Xing +4 more
doaj +1 more source
Journal of Investigative Surgery, 2022 Background To determine the effect of 131I treatment on postoperative parathyroid function and the timing of recovery of parathyroid function (RPF) in patients with protracted hypoPT.
Munire Abuduwaili +6 more
doaj +1 more source
Journal of Experimental & Clinical Cancer Research, 2021 Background Medullary thyroid cancer (MTC) represents 13.4 % of all thyroid cancers-related deaths. The treatments for MTC are very limited especially for patients with distal metastasis.
Xun Zheng +5 more
doaj +1 more source
BMC Cancer, 2022 Background Part of papillary thyroid microcarcinoma (PTMC) has a high risk of tumor invasion and metastasis, which may occur in the regional lymph node metastasis or distant metastasis, severely threatening the life of patients.
Xiuhe Zou +7 more
doaj +1 more source
Journal of Investigative Surgery, 2022 Purpose To evaluate the relationship between pre-operative 25-hydroxyvitamin D (25 (OH) D) levels and poor prognostic factors for papillary thyroid cancer (PTC). Methods A total of 1161 patients diagnosed with PTC were analyzed retrospectively.
Munire Abuduwaili +5 more
doaj +1 more source
Frontiers in Endocrinology, 2023 BackgroundTumor multifocality is frequently observed in papillary thyroid carcinoma (PTC). However, the maximum tumor diameter (MTD), currently utilized in various staging schemes, might not accurately indicate the level of aggressiveness exhibited by ...
Zhu-juan Wu +6 more
doaj +1 more source